Vaccine - (Page 9) 6164 M. Oviedo et al. / Vaccine 26 (2008) 6157–6164 [26] Zhou F, Shefer A, Weinbaum C, McCauley M, Kong Y. Impact of hepatitis A vaccination on health care utilization in the United States, 1996–2004. Vaccine 2007;25:3581–7. [27] Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol 2005;34: 600–9. [28] Dagan R, Amir J, Mijalovsky A, Bar-Yocahi A, Thoelen S, Safary A, et al. Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody. Pediatr Infect Dis J 2000;19:1045–52. [29] Werzberger A, Kuter B, Nalin D. Six years’ follow-up after hepatitis A vaccination. N Engl J Med 1998;338:1160. [30] MacIntyre CR, Burgess MA, Hull B, McIntyre PB. Hepatitis A vaccination options for Australia. J Paediatr Child Health 2003;39:83–7. [31] Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005;34:1329–39. [32] Taylor RM, Davern T, Fontana RJ, et al. Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes. Hepatology 2006;44:1589–97. [18] Institut d’Estadística de Catalunya (IDESCAT). Informació territorial: Banc d’estadístiques de municipis i comarques. Idescat 2007. (http://www.idescat. net/cat/poblacio/poblestructura.html). [19] Oviedo M, Munoz MP, Dominguez A, Carmona G. Estimated incidence of hepatitis A virus infection in Catalonia. Ann Epidemiol 2006;16:812–9. [20] Venables WN, Ripley BD. Modern applied statistics with S. Third ed. Springer; 2002. [21] McCullagh P, Nelder JA. Generalized linear models. Second ed. Chapman & Hall/CRC; 1989. ˜ [22] Borrás E, Domínguez A, Batalla J, Torner N, Cardenosa N, Nebot M, et al. Vaccination coverage in indigenous and immigrant children under 3 years of age in Catalonia (Spain). Vaccine 2007;25:3240–3. [23] Departament de Salut. Resum de les malalties de declaració obligatoria a Catalunya durant l’any 2003. Butlletí Epidemiològic de Catalunya 1999;XX: 119–33. [24] Samandari T, Bell BP, Armstrong GL. Quantifying the impact of hepatitis A immunization in the United States, 1995–2001. Vaccine 2004;22:4342–50. [25] Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA 2005;294:194–201. http://www.idescat.net/cat/poblacio/poblestructura.html http://www.idescat.net/cat/poblacio/poblestructura.html
Table of Contents Feed for the Digital Edition of Vaccine Vaccine Vaccine - (Page Cover1) Vaccine - (Page 2) Vaccine - (Page 3) Vaccine - (Page 4) Vaccine - (Page 5) Vaccine - (Page 6) Vaccine - (Page 7) Vaccine - (Page 8) Vaccine - (Page 9)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.